Intrinsiqq
Silexion Therapeutics Corp. logo

Silexion Therapeutics Corp. Quality Score

SLXN

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 12 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SLXN

CompareIntrinsic value
STROSutro Biopharma, Inc.
$8.60-1.38%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
CRDFCardiff Oncology Inc.
$0.85-4.18%36
LCTXLineage Cell Therapeutics Inc.
$0.77-5.87%10
FDMT4D Molecular Therapeutics, Inc.
$10.23-4.57%40
PROKProKidney Corp
$1.04-1.89%10
FENCFennec Pharmaceuticals Inc.
$13.10-2.60%50

Spot a number that looks wrong? Check it in SLXN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SLXN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.